Pharma healthcare focus Cyma specializes in collaborative construction solutions for pharmaceutical and healthcare sectors, presenting a strong opportunity to upsell EPCM and integrated project delivery services for regulated environments and complex facilities.

Recent client win Signs new agreement with Exela Pharma Sciences LLC for multiple facility projects, indicating appetite for ongoing EPCM leadership and potential multi-project engagements in NC, ideal for expanding into account-based selling and long-term programs.

Safety leadership Recent awards at safety and risk management events and demonstrated safety culture enhance credibility when pursuing work with high-stakes clients, enabling access to risk-sensitive bids and more favorable prequalification discussions.

Financial health Revenue range of 25 to 50 million places Cyma as a mid-market player with capacity for larger projects through partnerships or tiered contracting, suggesting opportunities for collaboration with larger firms on joint ventures or prime-sub roles.

Growth signals Experience across life science, corporate, education, and institutional sectors along with a scalable tech stack and ongoing lifecycle support offers cross-sell potential into adjacent markets and repeat-bid opportunities across project phases.